HomeSearchNeuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment

Dove Medical Press Ltd. · New Zealand · Est. 1971

ISSN1178-2021eISSN1178-2021
SJR Q2WOS SCIEScopus / SJRDOAJOpen Access
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.947
H-Indexi
120
SNIPi
0.872
Total Worksi
4,580
Total Citationsi
116,694
2yr Mean Citednessi
2.31
Open Impact Factor alternative
Retractions
25
Source: Retraction Watch

Aims & Scope

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

General Information

Country / RegionNew Zealand
Primary LanguageEnglish
1st Year Published1971
FrequencyAnnual, 2009-
StatusActive (last: 2026)
Total Publications4,580
Publisher OrgDove Medical Press
OA Since2007
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
OA LicenseCC BY, CC BY-NC
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

9/11 · 82%
Do you know the journal / publisher?
Dove Medical Press Ltd.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1178-2021 / 1178-2021
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
Peer review process documented?
Single-blind
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
335
8.5k
2019
325
9.6k
2020
351
6k
2021
271
3.7k
2022
249
2.7k
2023
228
1.2k
2024
218
526
2025
152
39
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Psychiatry and Mental HealthQ2
Biological PsychiatryQ3

Subject Classification

Web of Science Categories

Clinical NeurologyPsychiatry

Scopus Categories

Biological PsychiatryPsychiatry and Mental Health

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionTryptophan and brain disordersBipolar Disorder and TreatmentDementia and Cognitive Impairment ResearchAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesParkinson's Disease Mechanisms and TreatmentsAutism Spectrum Disorder ResearchEpilepsy research and treatment

Frequently asked questions about Neuropsychiatric Disease and Treatment

Is Neuropsychiatric Disease and Treatment a predatory journal?

PubScope has no integrity flags on record for Neuropsychiatric Disease and Treatment: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Neuropsychiatric Disease and Treatment?

Neuropsychiatric Disease and Treatment is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.31.

Is Neuropsychiatric Disease and Treatment indexed in Scopus and Web of Science?

Neuropsychiatric Disease and Treatment is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Neuropsychiatric Disease and Treatment?

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref